Asifin Placebo Forte® · Similia Series · 04

Mocha post Tabacum

C30 · Compositum · Globules, highly potentized

Highly potentized combination confection from the Similia Series. Two substrates (Caffeinum and Nicotinum), jointly potentized in C30 dilution according to the classical Hahnemann procedure, far beyond the Avogadro threshold. Application takes place after consultation in a defined social setting.

Desired state

For the desire for mental drift — distraction instead of focus.

Mocha post Tabacum C30 addresses the desire for mental drift in moments where coffee or cigarettes would otherwise be deployed as focus boosters. Recommended for activities that require free thought, lateral associations and idleness, and for situations of compulsive over-concentration in which letting go is hard.

Package insert

Mocha post Tabacum C30 (Compositum)

Asifin Placebo Forte® · Similia Series · 04 · Globules, highly potentized

Indication · Desired state

For application in the desire for mental drift, free association and letting go of focus. In compulsive over-concentration, ritualised focus stimulation and tunnel attention. Within creative activities, breaks and situations that require free thought.

Mechanism of action

Asifin Placebo Forte® · Similia Series acts through the classical homeopathic principle in C30 potency. Mocha post Tabacum is a compositum of two substrates (Caffeinum and Nicotinum), jointly potentized. The confection is pharmacologically without active ingredient — the dilution exceeds the Avogadro threshold (10⁻⁶⁰) and, by calculation, contains no molecule of either original substrate. The effect unfolds in the interplay of consultation, setting and individual expectation formation. The scientific foundation for effect analysis is provided through independent research by the Plankton Research Group.

Dosage and application

3 to 5 globules sublingually, once, after consultation. Application ideally at moments when coffee or a cigarette would otherwise be reached for — drift replacing activation. Consultation through the Asifin Placebo Forte® Consultation Bar or an authorised advisory location is recommended.

Notes

No pharmacological side effects to be expected. Social accompanying effects may occur: occasionally increased inclination toward topic shifts in conversation, surprising lateral connections and digression.

Interactions

None known. Fully compatible with prescribed medication, alcohol, food and other Similia Series applications.

Contraindications

None.

Use in special situations

Safe during pregnancy, breastfeeding, in advanced age, with chronic conditions and in parallel with other treatments. Suitable as a companion for activities that require free thought, idleness and lateral association.

Dependence potential

Pharmacological dependence potential: none. Ritual binding to the drift application is possible; this corresponds to the intended use.

Overdose

Excluded.

Dossier

Substrate combination

Compositum of two substrates, jointly potentized in C30.

Substrate A · Caffeinum

Trivial: Caffeine
IUPAC: 1,3,7-Trimethyl-1H-purine-2,6(3H,7H)-dione
Molecular formula: C₈H₁₀N₄O₂
Molar mass: 194.19 g/mol
CAS: 58-08-2
PubChem CID: 2519

Substrate B · Nicotinum

Trivial: Nicotine
IUPAC: (S)-3-(1-Methylpyrrolidin-2-yl)pyridine
Molecular formula: C₁₀H₁₄N₂
Molar mass: 162.23 g/mol
CAS: 54-11-5
PubChem CID: 89594

Substrate references from public databases. The confection contains, by calculation, no molecule of either substance.

Confection and provenance

Batch no.: APF-SS-MPT-001-2026-05
Format: Glass vial · 10 g · approx. 200 globules
Carrier: Sucrose, pharmacopoeial
Compositum method: parallel substrate potentization, joint impregnation
Production: Asifin Group · Vienna
Release: 2026-05-12
Shelf life: unlimited

Methodological accompaniment of effect research by the Plankton Research Group.

Dilution protocol · C1 to C30

One dilution series per substrate; merging into joint impregnation at step C30.

Step	Dilution factor	Note
C1	1 : 10²	Initial dilution in carrier liquid, per substrate
C6	1 : 10¹²	—
C12	1 : 10²⁴	Avogadro threshold · by calculation no molecule remaining
C24	1 : 10⁴⁸	—
C30	1 : 10⁶⁰	Compositum impregnation · joint loading of the globules

Dilution steps according to the classical C-potency series after Hahnemann. Succussion between steps according to pharmacopoeia.

Consultation

Application recommended after consultation in a defined setting.

The effect of the Similia Series unfolds together with the consultation. A consultant elicits the desired state, assigns the appropriate product and accompanies the application. The Asifin Placebo Forte® Consultation Bar is the primary advisory location.

Further products in the Similia Series

Similia Series · 01

Diacetylmorphinum C30

For the desire for mental clarity, alertness and presence.

Similia Series · 02

Cocainum C30

For the desire for calming, inner quiet and support in falling asleep.

Similia Series · 03

Ketaminum C30

For the desire for grounding, mental presence and sharpened perception.

Similia Series · 05

Discothecae Nonagintae C30

For the desire for fresh senses and anti-hangover recovery.